Evaluation of the Evolution of Patient Care Within the Spinal Pathology Department (SPINDATA)

May 29, 2026 updated by: University Hospital, Bordeaux

Evaluation of the Evolution of the Quality of Life of Patients Treated by the Spinal Pathology Department

Spinal conditions are a major public health issue. Their management by surgical treatment is constantly improving and surgical procedures or implantable medical devices are experiencing significant progress. These innovations have not yet all been precisely evaluated but have already led to significant changes in care practices. The primary objective of our study is to describe, via an exhaustive collection of data, the quarterly evolution over 5 years of practices in the management of spinal pathologies.

Study Overview

Detailed Description

The team will conduct a monocentric (department of spine surgery, University Hospital of Bordeaux, France) prospective observational study during 5 years, involving all patients treated for a spinal condition (including degenerative pathology of the lumbar, thoracic or cervical spine, deformities of the spine and for the traumatic, infectious and tumor pathologies).The data collected will concern the general condition of the patients, their reasons for consultation, the details of their spinal pathology and its impact using specific functional assessment self-questionnaires, as well as the care provided. A three years follow-up will be planned

Study Type

Interventional

Enrollment (Estimated)

15000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bordeaux, France, 33000
        • Recruiting
        • Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux
        • Contact:
        • Contact:
        • Principal Investigator:
          • Benjamin BOUYER, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

  • Patient > 18 years old
  • Minor patient, able to accept the data collection, with the consent of the holder(s)
  • Patient consulting for a medical reason involving a spinal pathology in the investigating center (spinal surgery department): Degenerative pathology of the thoracic or lumbar spine; Degenerative pathology of the cervical spine; Deformation of the spine; Urgent traumatic, infectious and tumor pathologies.

Exclusion criteria:

  • Patient under guardianship or curators,
  • Persons deprived of liberty by judicial or administrative decision,
  • Persons undergoing psychiatric treatment under duress requiring the consent of the legal representative
  • Persons unable to express their consent,
  • Persons under legal protection,
  • Patient not affiliated to a social protection scheme.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient consulting in spine surgery
quality of life scales for all patient consulting in spine surgery unit and psychological rating scales only for patients who require it (determined by the surgeon)
quality of life scales for all patient consulting in spine surgery unit and psychological rating scales only for patients who require it (determined by the surgeon)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recourse to surgery
Time Frame: Inclusion visit
Rate of recourse to surgery by type of spinal pathology given (cervical, thoracic or lumbar degenerative or spinal deformity).
Inclusion visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical characteristics
Time Frame: Inclusion visit, Visit Month 24 and Visit Month 36
Weight of patient
Inclusion visit, Visit Month 24 and Visit Month 36
Socio-demographic
Time Frame: Inclusion visit, Visit Month 24 and Visit Month 36
Socio-demographic characteristics (occupation)
Inclusion visit, Visit Month 24 and Visit Month 36
Socio-demographic
Time Frame: Inclusion visit, Visit Month 24 and Visit Month 36
Socio-demographic characteristics (sports activities)
Inclusion visit, Visit Month 24 and Visit Month 36
Questionnaire of Quality of life
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Health-related quality of life evaluated using the SF-36 questionnaire. This questionnaire is composed of 11 items and total score from 0 to 100
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Questionnaire of Quality of life
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Health-related quality of life evaluated using the EQ-5D-5L questionnaire. This questionnaire is composed of 5 items and total score from 5 to 25
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Lower back pain.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

The ODI (Oswestry Disability Index) score is used to measure the degree of disability related to lower back pain.

The questionnaire contains 10 items, each scored from 0 to 5 points. The maximum total score is 50 points.

Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Cervical pain
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

The NDI is used to measure disability related to cervical pain via a standardized questionnaire.

The questionnaire contains 10 items, each scored from 0 to 5 points. The maximum total score is 50 points.

The higher the percentage, the greater the functional impairment.

Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Cervical function, Upper limb function, Lower limb function, Bladder function, Quality of life.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

The JOACMEQ (Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire) provides 5 independent scores (0-100): Cervical function, Upper limb function, Lower limb function, Bladder function, Quality of life.

Each area gives a score between 0 (worst) and 100 (best condition).

Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Evaluation of the safety of care provided.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

For each type of spinal pathology, measurement of:

- Incidence of serious medical complications

Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Clinical characteristics
Time Frame: Inclusion visit, Visit Month 24 and Visit Month 36
Body Mass Index of patient
Inclusion visit, Visit Month 24 and Visit Month 36
Evaluation of the safety of care provided.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
For each type of spinal pathology, measurement of Incidence of mortality, assessed by recalling patients lost to follow-up
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Evaluation of the safety of care provided.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
For each type of spinal pathology, measurement of Incidence of surgical site infections
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Evaluation of the safety of care provided.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
For each type of spinal pathology, measurement of Incidence of mechanical complications
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Evaluation of the safety of care provided.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
For each type of spinal pathology, measurement of Incidence of neurological complications
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
Evaluation of the safety of care provided.
Time Frame: Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits
For each type of spinal pathology, measurement of Incidence of surgical re-interventions
Inclusion visit, Month 3, Month 6, Month 12, Month 24 and Month 36 visits

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benjamin BOUYER, PROF, University Hospital, Bordeaux

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2023

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2031

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

May 29, 2026

First Posted (Actual)

June 4, 2026

Study Record Updates

Last Update Posted (Actual)

June 4, 2026

Last Update Submitted That Met QC Criteria

May 29, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Stenosis

Clinical Trials on self-administered questionnaire

Subscribe